Your browser doesn't support javascript.
loading
Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110.
Hengeveld, Paul J; Ertem, Y Emre; Dubois, Julie M N; Mellink, Clemens H M; van der Kevie-Kersemaekers, Anne-Marie; Evers, Ludo M; Heezen, Kim; Kolijn, P Martijn; Mook, Olaf R F; Motazacker, M Mahdi; Nasserinejad, Kazem; Kersting, S; Westerweel, Peter E; Niemann, Carsten U; Kater, Arnon P; Langerak, Anton W; Levin, Mark-David.
Afiliación
  • Hengeveld PJ; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
  • Ertem YE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Dubois JMN; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
  • Mellink CHM; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van der Kevie-Kersemaekers AM; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Evers LM; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Heezen K; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Kolijn PM; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
  • Mook ORF; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
  • Motazacker MM; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Nasserinejad K; Department of Human Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Kersting S; HOVON Data Center, Dept. of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Westerweel PE; Department of Hematology, Haga Hospital, The Hague, The Netherlands.
  • Niemann CU; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Kater AP; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Langerak AW; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Levin MD; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Leukemia ; 36(7): 1935-1938, 2022 07.
Article en En | MEDLINE | ID: mdl-35585140
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos